JP2023501789A5 - - Google Patents
Info
- Publication number
- JP2023501789A5 JP2023501789A5 JP2022525877A JP2022525877A JP2023501789A5 JP 2023501789 A5 JP2023501789 A5 JP 2023501789A5 JP 2022525877 A JP2022525877 A JP 2022525877A JP 2022525877 A JP2022525877 A JP 2022525877A JP 2023501789 A5 JP2023501789 A5 JP 2023501789A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- amorphous form
- further characterized
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025171004A JP2026016449A (ja) | 2019-11-08 | 2025-10-09 | 補体成分C5a受容体の非晶質形態 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962932644P | 2019-11-08 | 2019-11-08 | |
| US62/932,644 | 2019-11-08 | ||
| PCT/US2020/059280 WO2021092286A1 (en) | 2019-11-08 | 2020-11-06 | Amorphous form of a complement component c5a receptor |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171004A Division JP2026016449A (ja) | 2019-11-08 | 2025-10-09 | 補体成分C5a受容体の非晶質形態 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023501789A JP2023501789A (ja) | 2023-01-19 |
| JP2023501789A5 true JP2023501789A5 (cg-RX-API-DMAC7.html) | 2023-11-10 |
Family
ID=75846408
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022525877A Pending JP2023501789A (ja) | 2019-11-08 | 2020-11-06 | 補体成分C5a受容体の非晶質形態 |
| JP2025171004A Pending JP2026016449A (ja) | 2019-11-08 | 2025-10-09 | 補体成分C5a受容体の非晶質形態 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025171004A Pending JP2026016449A (ja) | 2019-11-08 | 2025-10-09 | 補体成分C5a受容体の非晶質形態 |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020380367B2 (en) | 2019-11-08 | 2026-06-04 | Chemocentryx, Inc. | Salt forms of a complement component C5a receptor |
| KR20220098754A (ko) | 2019-11-08 | 2022-07-12 | 케모센트릭스, 인크. | 보체 성분 C5a 수용체의 비정질 형태 |
| WO2022078269A1 (zh) * | 2020-10-16 | 2022-04-21 | 苏州科睿思制药有限公司 | Avacopan的晶型及其制备方法和用途 |
| WO2022263263A1 (en) | 2021-06-16 | 2022-12-22 | Sandoz Ag | Crystalline form of avacopan |
| EP4137133A1 (en) | 2021-08-19 | 2023-02-22 | Sandoz AG | Crystalline form of avacopan |
| WO2025227089A1 (en) | 2024-04-26 | 2025-10-30 | Amgen Inc. | Solid state forms of (2r,3s)-2-(4-(cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-n-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide |
| US20260027049A1 (en) | 2024-07-23 | 2026-01-29 | Amgen Inc. | Avacopan formulations |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101031548B (zh) | 2004-09-27 | 2011-04-06 | 阿卡蒂亚药品公司 | N-(4-氟苄基)-n-(1-甲基哌啶-4-基)-n'-(4-(2-甲基丙氧基)-苯基甲基)脲的盐及其制备 |
| JP5819730B2 (ja) | 2008-12-22 | 2015-11-24 | ケモセントリックス,インコーポレイティド | C5aRアンタゴニスト |
| US20110275639A1 (en) | 2008-12-22 | 2011-11-10 | Chemocentryx, Inc. | C5aR ANTAGONISTS |
| DK2585064T3 (en) | 2010-06-24 | 2017-07-24 | Chemocentryx Inc | C5aR antagonists |
| JP6898229B6 (ja) * | 2014-09-29 | 2021-07-28 | ケモセントリックス,インコーポレイティド | C5aRアンタゴニスト製造における方法及び中間体 |
| KR20200109297A (ko) | 2017-10-31 | 2020-09-22 | 케모센트릭스, 인크. | 소변 sCD163의 C5aR 억제제 감소 |
| JP2021527062A (ja) | 2018-06-07 | 2021-10-11 | ケモセントリックス,インコーポレイティド | ANCA関連血管炎に対するc5aアンタゴニストの投薬及び効果 |
| CN113164403A (zh) | 2018-11-30 | 2021-07-23 | 凯莫森特里克斯股份有限公司 | 胶囊制剂 |
| BR112021017756A2 (pt) | 2019-03-11 | 2021-11-16 | Inflarx Gmbh | Piperidinila bicíclica fundida e compostos relacionados como moduladores do receptor c5a |
| AU2020378061A1 (en) | 2019-11-08 | 2022-05-26 | Chemocentryx, Inc. | Free base crystalline form of a complement component C5a receptor |
| KR20220098754A (ko) | 2019-11-08 | 2022-07-12 | 케모센트릭스, 인크. | 보체 성분 C5a 수용체의 비정질 형태 |
| AU2020380367B2 (en) | 2019-11-08 | 2026-06-04 | Chemocentryx, Inc. | Salt forms of a complement component C5a receptor |
| WO2022078269A1 (zh) | 2020-10-16 | 2022-04-21 | 苏州科睿思制药有限公司 | Avacopan的晶型及其制备方法和用途 |
-
2020
- 2020-11-06 KR KR1020227018914A patent/KR20220098754A/ko not_active Ceased
- 2020-11-06 CA CA3155542A patent/CA3155542A1/en active Pending
- 2020-11-06 JP JP2022525877A patent/JP2023501789A/ja active Pending
- 2020-11-06 US US17/091,001 patent/US11603356B2/en active Active
- 2020-11-06 IL IL292383A patent/IL292383A/en unknown
- 2020-11-06 AU AU2020378397A patent/AU2020378397A1/en active Pending
- 2020-11-06 MX MX2022005406A patent/MX2022005406A/es unknown
- 2020-11-06 CN CN202080077440.0A patent/CN114641288A/zh active Pending
- 2020-11-06 BR BR112022007489A patent/BR112022007489A2/pt unknown
- 2020-11-06 EP EP20883775.7A patent/EP4054576A4/en active Pending
- 2020-11-06 WO PCT/US2020/059280 patent/WO2021092286A1/en not_active Ceased
- 2020-11-06 TW TW109138756A patent/TWI921314B/zh active
-
2022
- 2022-05-04 CL CL2022001172A patent/CL2022001172A1/es unknown
-
2023
- 2023-05-25 ZA ZA2023/05624A patent/ZA202305624B/en unknown
-
2025
- 2025-10-09 JP JP2025171004A patent/JP2026016449A/ja active Pending